Sep 9, 2026 06:11AM
Jul 31, 2026 06:47AM
Jul 30, 2026 01:04PM
Jul 30, 2026 07:36AM
Jun 17, 2026 06:50AM
Apr 30, 2026 07:06AM
Mar 27, 2026 03:39AM Barclays Upgrades Phathom Pharmaceuticals (PHAT) to Overweight
Mar 19, 2026 02:33PM
Mar 5, 2026 01:08PM
Feb 27, 2026 06:55AM
Feb 26, 2026 12:51PM
Feb 26, 2026 07:36AM
Jan 15, 2026 07:24AM
Jan 14, 2026 06:59AM Phathom Pharmaceuticals (PHAT) Reiterated at Overweight at Cantor Fitzgerald
Dec 11, 2025 04:05PM
Oct 30, 2025 12:03PM
Oct 30, 2025 07:17AM
Oct 15, 2025 06:59AM
Oct 9, 2025 07:13AM
Oct 6, 2025 08:00AM
Aug 20, 2025 08:02AM Phathom clarifies no reduction in Frazier ownership despite filing changes
Aug 7, 2025 07:00AM
Jun 16, 2025 08:01AM
Jun 9, 2025 06:40AM
Jun 9, 2025 05:15AM
Jun 9, 2025 03:25AM
Jun 6, 2025 01:46PM
Jun 6, 2025 01:16PM Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald
Jun 6, 2025 12:48PM
Jun 6, 2025 12:28PM
Jun 6, 2025 11:52AM
Jun 6, 2025 11:51AM
May 2, 2025 07:27AM
May 1, 2025 07:06AM
Apr 16, 2025 08:02AM Phathom Pharmaceuticals Inc. (PHAT) Appoints Ted Schroeder to its Board of Directors
Apr 1, 2025 08:01AM
Mar 31, 2025 08:00AM
Mar 19, 2025 02:58PM
Mar 7, 2025 06:44AM
Mar 6, 2025 04:24PM
Mar 6, 2025 12:25PM
Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs
Feb 7, 2025 01:34PM
Dec 12, 2024 06:44AM
Dec 11, 2024 09:38AM
Nov 7, 2024 01:51PM
Nov 7, 2024 08:08AM
Aug 19, 2024 08:01AM
Aug 8, 2024 04:17PM Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs
Aug 8, 2024 02:53PM

448,359 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All